A vaccine targeting gonorrhea will soon be rolled out on the NHS. This will make England and Wales the first two countries in ...

Research has shown that the 4CMenB vaccine provides some protection against an infection from the Neisseria gonorrhoeae ...

The pivotal AMPLIFY trial aims to support FDA approval of ⁶⁴Cu-SAR-bisPSMA as a best-in-class imaging tool in prostate cancer ...

Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to ...

Immutep’s efti with radiotherapy and pembrolizumab meets primary endpoint in phase II trials for soft tissue sarcoma ...

Gene editing is a powerful technique which opens the possibility of genetic therapies which can rectify mutations which normally lead to disease. The use of ...

Tissue-specific immune memory has become a central focus in immunology, drawing attention to the distinct roles of tissue-resident memory lymphocytes, their ...

Fate Therapeutics, Inc. (NASDAQ:FATE) announced today that it will present groundbreaking clinical data from its Phase 1 ...